Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Double-blind comparison of the efficacy and safety of trandolapril 2 mg and hydrochlorothiazide 25 mg in patients with mild-to-moderate essential hypertension
Journal of Cardiovascular Pharmacology, Volume 23, Year 1994
Notification
URL copied to clipboard!
Description
This multicenter international trial recruited 205 patients from 16 investigators. After a 4-week, single-blind placebo run-in, patients were randomized to receive 16 weeks of trandolapril 2 mg/day (68 patients), hydrochlorothiazide (HCTZ) 25 mg/day (68 patients), or the combination (69 patients). Morning predosing supine diastolic blood pressure (DBP) was the primary efficacy measurement. Intention-to-treat analysis showed significant decreases in all three groups in mean (± SEM) supine DBP throughout the study, with no significant differences at week 16 between trandolapril (-10.6 ± 1.3 mm Hg) and HCTZ (-10.9 ± 1.3 mm Hg). The combination gave a significantly greater reduction than either drug alone (-15.1 ± 1.13 mm Hg). Blood pressure was normalized in the combination group in 67% of patients, a significantly higher proportion than either trandolapril (63%) or HCTZ (60%; p = 0.04). Each treatment was well tolerated. The incidence of adverse events was similar in all three groups. Trandolapril 2 mg once daily is an effective antihypertensive agent, comparable to HCTZ. Furthermore, the combination of the two drugs was shown to enhance the antihypertensive effect of the two compounds alone. © 1994 Raven Press, Ltd., New York.
Authors & Co-Authors
Meyer, Bernhardt H.
South Africa, Bloemfontein
University of the Free State
Pauly, Nancy C.
France, Gentilly
Sanofi S.a.
Meyer, Brigitte H.
Unknown Affiliation
Douret, G.
Unknown Affiliation
Roex, M.
Unknown Affiliation
Joehcms, G.
Unknown Affiliation
Verhulst, A.
Unknown Affiliation
Wester, A.
Unknown Affiliation
Lustcrmans, F.
Unknown Affiliation
Lewis, M.
Unknown Affiliation
Stanley, N.
Unknown Affiliation
Moulopoulos, S.
Unknown Affiliation
Pasz, T.
Unknown Affiliation
Bouzo, Hischam
Unknown Affiliation
Rau, R.
Unknown Affiliation
Geser, C.
Unknown Affiliation
Hitzcnberger, G.
Unknown Affiliation
Crivelli, C.
Unknown Affiliation
Statistics
Citations: 18
Authors: 18
Affiliations: 2
Identifiers
Doi:
10.1097/00005344-199400234-00015
ISSN:
01602446
e-ISSN:
15334023
Research Areas
Disability
Noncommunicable Diseases
Study Design
Cohort Study